BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Biron CA. Interferons alpha and beta as immune regulators--a new look. Immunity. 2001;14:661-664. [PMID: 11420036 DOI: 10.1016/s1074-7613(01)00154-6] [Cited by in Crossref: 527] [Cited by in F6Publishing: 188] [Article Influence: 26.4] [Reference Citation Analysis]
Number Citing Articles
1 Domeika K, Magnusson M, Eloranta ML, Fuxler L, Alm GV, Fossum C. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet Immunol Immunopathol 2004;101:87-102. [PMID: 15261695 DOI: 10.1016/j.vetimm.2004.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
2 Carr DJ, Austin BA, Halford WP, Stuart PM. Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways. J Neuroimmunol 2009;206:39-43. [PMID: 19042034 DOI: 10.1016/j.jneuroim.2008.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
3 Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, Chisari FV. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 2002;99:15661-8. [PMID: 12441397 DOI: 10.1073/pnas.202608299] [Cited by in Crossref: 468] [Cited by in F6Publishing: 441] [Article Influence: 24.6] [Reference Citation Analysis]
4 Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res. 2010;30:555-564. [PMID: 20712453 DOI: 10.1089/jir.2010.0078] [Cited by in Crossref: 272] [Cited by in F6Publishing: 244] [Article Influence: 27.2] [Reference Citation Analysis]
5 Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 2013;38:119-30. [PMID: 23246311 DOI: 10.1016/j.immuni.2012.09.016] [Cited by in Crossref: 202] [Cited by in F6Publishing: 183] [Article Influence: 22.4] [Reference Citation Analysis]
6 Ousman SS, Wang J, Campbell IL. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol 2005;79:7514-27. [PMID: 15919906 DOI: 10.1128/JVI.79.12.7514-7527.2005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
7 Soto JA, Gálvez NMS, Benavente FM, Pizarro-Ortega MS, Lay MK, Riedel C, Bueno SM, Gonzalez PA, Kalergis AM. Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System. Front Immunol 2018;9:2466. [PMID: 30405642 DOI: 10.3389/fimmu.2018.02466] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
8 Hassan A, Wlodarczyk MF, Benamar M, Bassot E, Salvioni A, Kassem S, Berry A, Saoudi A, Blanchard N. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner. mBio 2020;11:e03394-19. [PMID: 32265335 DOI: 10.1128/mBio.03394-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Appolinário CM, Allendorf SD, Peres MG, Ribeiro BD, Fonseca CR, Vicente AF, Antunes JM, Megid J. Profile of Cytokines and Chemokines Triggered by Wild-Type Strains of Rabies Virus in Mice. Am J Trop Med Hyg 2016;94:378-83. [PMID: 26711511 DOI: 10.4269/ajtmh.15-0361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
10 Koka R, Burkett PR, Chien M, Chai S, Chan F, Lodolce JP, Boone DL, Ma A. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 2003;197:977-84. [PMID: 12695489 DOI: 10.1084/jem.20021836] [Cited by in Crossref: 191] [Cited by in F6Publishing: 180] [Article Influence: 10.6] [Reference Citation Analysis]
11 Donelan NR, Basler CF, García-Sastre A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 2003;77:13257-66. [PMID: 14645582 DOI: 10.1128/jvi.77.24.13257-13266.2003] [Cited by in Crossref: 215] [Cited by in F6Publishing: 143] [Article Influence: 12.6] [Reference Citation Analysis]
12 Kovarik P, Sauer I, Schaljo B. Molecular mechanisms of the anti-inflammatory functions of interferons. Immunobiology 2007;212:895-901. [PMID: 18086388 DOI: 10.1016/j.imbio.2007.09.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
13 Tailor P, Tamura T, Kong HJ, Kubota T, Kubota M, Borghi P, Gabriele L, Ozato K. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007;27:228-39. [PMID: 17702615 DOI: 10.1016/j.immuni.2007.06.009] [Cited by in Crossref: 128] [Cited by in F6Publishing: 124] [Article Influence: 9.1] [Reference Citation Analysis]
14 Shibuya H, Nagai T, Ishii A, Yamamoto K, Hirohata S. Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha. Clin Exp Immunol 2003;132:216-24. [PMID: 12699408 DOI: 10.1046/j.1365-2249.2003.02128.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 2009;5:72-83. [PMID: 19154989 DOI: 10.1016/j.chom.2008.11.008] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 8.0] [Reference Citation Analysis]
16 Schmidlin H, Dontje W, Groot F, Ligthart SJ, Colantonio AD, Oud ME, Schilder-Tol EJ, Spaargaren M, Spits H, Uittenbogaart CH, Blom B. Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood 2006;108:3792-800. [PMID: 16917011 DOI: 10.1182/blood-2006-02-004978] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
17 Gigli G, Caielli S, Cutuli D, Falcone M. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. Immunology 2007;122:409-17. [PMID: 17617156 DOI: 10.1111/j.1365-2567.2007.02655.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
18 Bauler TJ, Chase JC, Bosio CM. IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis. J Immunol 2011;187:1845-55. [PMID: 21753150 DOI: 10.4049/jimmunol.1100377] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
19 Rönnblom L, Alm GV. Systemic lupus erythematosus and the type I interferon system. Arthritis Res Ther 2003;5:68-75. [PMID: 12718746 DOI: 10.1186/ar625] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 5.2] [Reference Citation Analysis]
20 Jin YH, Kaneyama T, Kang MH, Kang HS, Koh CS, Kim BS. TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection. J Neuroinflammation 2011;8:178. [PMID: 22189096 DOI: 10.1186/1742-2094-8-178] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
21 Kuchtey J, Fulton SA, Reba SM, Harding CV, Boom WH. Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology 2006;118:39-49. [PMID: 16630021 DOI: 10.1111/j.1365-2567.2006.02337.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
22 Yan M, Luo JK, Ritchie KJ, Sakai I, Takeuchi K, Ren R, Zhang DE. Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling. Blood 2007;110:305-12. [PMID: 17374743 DOI: 10.1182/blood-2006-07-033209] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
23 Parker LC, Prince LR, Sabroe I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol. 2007;147:199-207. [PMID: 17223959 DOI: 10.1111/j.1365-2249.2006.03203.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 106] [Article Influence: 8.6] [Reference Citation Analysis]
24 Abate DA, Watanabe S, Mocarski ES. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 2004;78:10995-1006. [PMID: 15452220 DOI: 10.1128/JVI.78.20.10995-11006.2004] [Cited by in Crossref: 142] [Cited by in F6Publishing: 97] [Article Influence: 8.4] [Reference Citation Analysis]
25 Jin YH, Hou W, Kim SJ, Fuller AC, Kang B, Goings G, Miller SD, Kim BS. Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS. J Neuroimmunol 2010;226:27-37. [PMID: 20538350 DOI: 10.1016/j.jneuroim.2010.05.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
26 Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 2003;77:7945-56. [PMID: 12829834 DOI: 10.1128/jvi.77.14.7945-7956.2003] [Cited by in Crossref: 344] [Cited by in F6Publishing: 230] [Article Influence: 19.1] [Reference Citation Analysis]
27 Kim TW, Hong S, Lin Y, Murat E, Joo H, Kim T, Pascual V, Liu YJ. Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic Cells. J Immunol 2016;197:3348-59. [PMID: 27630164 DOI: 10.4049/jimmunol.1502385] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
28 Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J 2003;22:5480-90. [PMID: 14532120 DOI: 10.1093/emboj/cdg524] [Cited by in Crossref: 138] [Cited by in F6Publishing: 143] [Article Influence: 8.1] [Reference Citation Analysis]
29 Pembroke T, Rees I, Gallagher K, Jones E, Mizen P, Navruzov T, Freedman A, Fielding C, Humphreys IR, Wang EC. Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity. Eur J Immunol. 2012;42:2383-2394. [PMID: 22653709 DOI: 10.1002/eji.201142072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
30 Gil MP, Salomon R, Louten J, Biron CA. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 2006;107:987-93. [PMID: 16210337 DOI: 10.1182/blood-2005-07-2834] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
31 Seo YJ, Hahm B. Type I interferon modulates the battle of host immune system against viruses. Adv Appl Microbiol. 2010;73:83-101. [PMID: 20800760 DOI: 10.1016/s0065-2164(10)73004-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
32 Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010;234:142-62. [PMID: 20193017 DOI: 10.1111/j.0105-2896.2009.00881.x] [Cited by in Crossref: 284] [Cited by in F6Publishing: 266] [Article Influence: 25.8] [Reference Citation Analysis]
33 Zhu H, Butera M, Nelson DR, Liu C. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J 2005;2:80. [PMID: 16146571 DOI: 10.1186/1743-422X-2-80] [Cited by in Crossref: 63] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
34 Lasfar A, Abushahba W, Balan M, Cohen-Solal KA. Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol 2011;2011:349575. [PMID: 22190970 DOI: 10.1155/2011/349575] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
35 Zorzitto J, Galligan CL, Ueng JJ, Fish EN. Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro. Cell Res 2006;16:220-9. [PMID: 16474437 DOI: 10.1038/sj.cr.7310030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
36 Doughty LA, Carlton S, Galen B, Cooma-Ramberan I, Chung CS, Ayala A. Activation of common antiviral pathways can potentiate inflammatory responses to septic shock. Shock 2006;26:187-94. [PMID: 16878028 DOI: 10.1097/01.shk.0000223129.79759.74] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
37 Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, Bloom CI, Chaussabel D, Banchereau J, Brett SJ, Moffatt MF, O'Garra A, Openshaw PJM; MOSAIC Investigators. Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza. Nat Immunol 2018;19:625-35. [PMID: 29777224 DOI: 10.1038/s41590-018-0111-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 24.0] [Reference Citation Analysis]
38 Mao S, Wang M, Ou X, Sun D, Cheng A, Zhu D, Chen S, Jia R, Liu M, Sun K, Yang Q, Wu Y, Zhao X, Chen X. Virologic and Immunologic Characteristics in Mature Ducks with Acute Duck Hepatitis A Virus 1 Infection. Front Immunol 2017;8:1574. [PMID: 29201029 DOI: 10.3389/fimmu.2017.01574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
39 Bowen JL, Olson JK. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease. Viral Immunol 2013;26:223-38. [PMID: 23829778 DOI: 10.1089/vim.2013.0004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
40 Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, Chisari FV. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA. 2002;99:15661-15668. [PMID: 12441397 DOI: 10.1073/pnas.202608] [Reference Citation Analysis]
41 Weiss EM, Wunderlich R, Ebel N, Rubner Y, Schlücker E, Meyer-Pittroff R, Ott OJ, Fietkau R, Gaipl US, Frey B. Selected anti-tumor vaccines merit a place in multimodal tumor therapies. Front Oncol 2012;2:132. [PMID: 23087898 DOI: 10.3389/fonc.2012.00132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
42 Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD, Biron CA. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 2003;197:885-98. [PMID: 12682109 DOI: 10.1084/jem.20021522] [Cited by in Crossref: 274] [Cited by in F6Publishing: 265] [Article Influence: 15.2] [Reference Citation Analysis]
43 Li HS, Watowich SS. A STATus report on DC development. J Leukoc Biol 2012;92:445-59. [PMID: 22550127 DOI: 10.1189/jlb.0212052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
44 Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flaño E. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J Virol 2007;81:9778-89. [PMID: 17626106 DOI: 10.1128/JVI.00360-07] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
45 Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest. 2005;115:695-702. [PMID: 15765149 DOI: 10.1172/jci22996] [Cited by in Crossref: 271] [Cited by in F6Publishing: 180] [Article Influence: 16.9] [Reference Citation Analysis]
46 Johnson RM. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun 2004;72:3951-60. [PMID: 15213139 DOI: 10.1128/IAI.72.7.3951-3960.2004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
47 Mundy-Bosse BL, Young GS, Bauer T, Binkley E, Bloomston M, Bill MA, Bekaii-Saab T, Carson WE 3rd, Lesinski GB. Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy. Cancer Immunol Immunother 2011;60:1269-79. [PMID: 21604071 DOI: 10.1007/s00262-011-1029-z] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 9.7] [Reference Citation Analysis]
48 Ragimbeau J, Dondi E, Alcover A, Eid P, Uzé G, Pellegrini S. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J 2003;22:537-47. [PMID: 12554654 DOI: 10.1093/emboj/cdg038] [Cited by in Crossref: 146] [Cited by in F6Publishing: 141] [Article Influence: 8.1] [Reference Citation Analysis]
49 Tsai KN, Chong CL, Chou YC, Huang CC, Wang YL, Wang SW, Chen ML, Chen CH, Chang C. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly. J Virol 2015;89:11406-19. [PMID: 26339052 DOI: 10.1128/JVI.00949-15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
50 Liu R, Chen Y, Guo J, Li M, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Zhang H, Xie Y. The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients. BMC Infect Dis 2020;20:590. [PMID: 32778058 DOI: 10.1186/s12879-020-05320-z] [Reference Citation Analysis]
51 Zucchini N, Bessou G, Robbins SH, Chasson L, Raper A, Crocker PR, Dalod M. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int Immunol 2008;20:45-56. [PMID: 18000008 DOI: 10.1093/intimm/dxm119] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
52 Yamin R, Kaynan NS, Glasner A, Vitenshtein A, Tsukerman P, Bauman Y, Ophir Y, Elias S, Bar-On Y, Gur C, Mandelboim O. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors. PLoS Pathog 2013;9:e1003568. [PMID: 23966863 DOI: 10.1371/journal.ppat.1003568] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
53 Chasset F, Dayer JM, Chizzolini C. Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment. Front Pharmacol 2021;12:633821. [PMID: 33986670 DOI: 10.3389/fphar.2021.633821] [Reference Citation Analysis]
54 Kempaiah P, Anyona SB, Raballah E, Davenport GC, Were T, Hittner JB, Ong'echa JM, Perkins DJ. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality. Hum Genet 2012;131:1375-91. [PMID: 22570109 DOI: 10.1007/s00439-012-1175-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
55 Schwandt T, Schumak B, Gielen GH, Jüngerkes F, Schmidbauer P, Klocke K, Staratschek-Jox A, van Rooijen N, Kraal G, Ludwig-Portugall I, Franken L, Wehner S, Kalff JC, Weber O, Kirschning C, Coch C, Kalinke U, Wenzel J, Kurts C, Zawatzky R, Holzmann B, Layland L, Schultze JL, Burgdorf S, den Haan JM, Knolle PA, Limmer A. Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. EMBO J 2012;31:201-13. [PMID: 22036947 DOI: 10.1038/emboj.2011.380] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
56 Nakayama Y, Plisch EH, Sullivan J, Thomas C, Czuprynski CJ, Williams BR, Suresh M. Role of PKR and Type I IFNs in viral control during primary and secondary infection. PLoS Pathog 2010;6:e1000966. [PMID: 20585572 DOI: 10.1371/journal.ppat.1000966] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
57 Rodriguez JJ, Parisien JP, Horvath CM. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol. 2002;76:11476-11483. [PMID: 12388709 DOI: 10.1128/jvi.76.22.11476-11483.2002] [Cited by in Crossref: 210] [Cited by in F6Publishing: 127] [Article Influence: 11.1] [Reference Citation Analysis]
58 Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006;203:1891-901. [PMID: 16831897 DOI: 10.1084/jem.20051725] [Cited by in Crossref: 159] [Cited by in F6Publishing: 150] [Article Influence: 10.6] [Reference Citation Analysis]
59 Burkart C, Fan JB, Zhang DE. Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus. J Biol Chem 2012;287:4883-93. [PMID: 22170061 DOI: 10.1074/jbc.M111.255570] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
60 Jin YH, Kim SJ, So EY, Meng L, Colonna M, Kim BS. Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease. J Virol 2012;86:1531-43. [PMID: 22090123 DOI: 10.1128/JVI.06457-11] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
61 Bekeredjian-Ding I, Schäfer M, Hartmann E, Pries R, Parcina M, Schneider P, Giese T, Endres S, Wollenberg B, Hartmann G. Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology 2009;128:439-50. [PMID: 20067543 DOI: 10.1111/j.1365-2567.2009.03134.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
62 Skjesol A, Skjæveland I, Elnæs M, Timmerhaus G, Fredriksen BN, Jørgensen SM, Krasnov A, Jørgensen JB. IPNV with high and low virulence: host immune responses and viral mutations during infection. Virol J 2011;8:396. [PMID: 21827718 DOI: 10.1186/1743-422X-8-396] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 6.1] [Reference Citation Analysis]
63 Barchet W, Blasius A, Cella M, Colonna M. Plasmacytoid dendritic cells: in search of their niche in immune responses. Immunol Res 2005;32:75-83. [PMID: 16106060 DOI: 10.1385/IR:32:1-3:075] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, Perry AK, Nguyen BO, Lane TF, Taniguchi T, Miller JF, Cheng G. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 2004;200:437-45. [PMID: 15302901 DOI: 10.1084/jem.20040712] [Cited by in Crossref: 379] [Cited by in F6Publishing: 368] [Article Influence: 22.3] [Reference Citation Analysis]
65 Gimeno R, Lee CK, Schindler C, Levy DE. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol Cell Biol. 2005;25:5456-5465. [PMID: 15964802 DOI: 10.1128/MCB.25.13.5456-5465.2005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
66 Roth-Cross JK, Martínez-Sobrido L, Scott EP, García-Sastre A, Weiss SR. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol. 2007;81:7189-7199. [PMID: 17459917 DOI: 10.1128/JVI.00013-07] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
67 Xu D, Han Q, Hou Z, Zhang C, Zhang J. miR-146a negatively regulates NK cell functions via STAT1 signaling. Cell Mol Immunol. 2017;14:712-720. [PMID: 26996068 DOI: 10.1038/cmi.2015.113] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
68 Olson JK, Miller SD. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. J Immunol 2009;182:5712-22. [PMID: 19380818 DOI: 10.4049/jimmunol.0801940] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
69 Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med. 2005;202:637-650. [PMID: 16129706 DOI: 10.1084/jem.20050821] [Cited by in Crossref: 620] [Cited by in F6Publishing: 607] [Article Influence: 38.8] [Reference Citation Analysis]
70 Korthals M, Safaian N, Kronenwett R, Maihöfer D, Schott M, Papewalis C, Diaz Blanco E, Winter M, Czibere A, Haas R, Kobbe G, Fenk R. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med 2007;5:46. [PMID: 17894866 DOI: 10.1186/1479-5876-5-46] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
71 Tversky JR, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function. Clin Exp Allergy 2010;40:94-102. [PMID: 20205698 DOI: 10.1111/j.1365-2222.2009.03388.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
72 Nudelman I, Akabayov SR, Schnur E, Biron Z, Levy R, Xu Y, Yang D, Anglister J. Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY. Biochemistry 2010;49:5117-33. [PMID: 20496919 DOI: 10.1021/bi100041f] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
73 Zekri AR, Bahnassy AA, Mohamed WS, Alam El-Din HM, Shousha HI, Zayed N, Eldahshan DH, Abdel-Aziz AO. Dynamic interplay between CXCL levels in chronic hepatitis C patients treated by interferon. Virol J. 2013;10:218. [PMID: 23816271 DOI: 10.1186/1743-422x-10-218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
74 Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343-51. [PMID: 11828009 DOI: 10.1084/jem.20011149] [Cited by in Crossref: 723] [Cited by in F6Publishing: 677] [Article Influence: 38.1] [Reference Citation Analysis]
75 Swiecki M, Colonna M. Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr Opin Virol 2011;1:463-75. [PMID: 22440910 DOI: 10.1016/j.coviro.2011.10.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
76 Ioannidis I, Ye F, McNally B, Willette M, Flaño E. Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol 2013;87:3261-70. [PMID: 23302870 DOI: 10.1128/JVI.01956-12] [Cited by in Crossref: 123] [Cited by in F6Publishing: 86] [Article Influence: 15.4] [Reference Citation Analysis]
77 Qu J, Hou Z, Han Q, Jiang W, Zhang C, Tian Z, Zhang J. Intracellular poly(I:C) initiated gastric adenocarcinoma cell apoptosis and subsequently ameliorated NK cell functions. J Interferon Cytokine Res 2014;34:52-9. [PMID: 24032591 DOI: 10.1089/jir.2012.0118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
78 Chen DS, Davis MM. Cellular immunotherapy: antigen recognition is just the beginning. Springer Semin Immunopathol 2005;27:119-27. [PMID: 15834723 DOI: 10.1007/s00281-005-0200-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
79 Pascal LE, Wang Y, Zhong M, Wang D, Chakka AB, Yang Z, Li F, Song Q, Rigatti LH, Chaparala S, Chandran U, Parwani AV, Wang Z. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. Neoplasia 2018;20:351-63. [PMID: 29518696 DOI: 10.1016/j.neo.2018.01.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
80 Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, Trinchieri G, Caux C, Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005;201:1435-46. [PMID: 15851485 DOI: 10.1084/jem.20041964] [Cited by in Crossref: 400] [Cited by in F6Publishing: 376] [Article Influence: 25.0] [Reference Citation Analysis]
81 Kumar A, Zhang J, Yu FS. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology 2006;117:11-21. [PMID: 16423036 DOI: 10.1111/j.1365-2567.2005.02258.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 135] [Article Influence: 8.8] [Reference Citation Analysis]
82 Tarhini AA, Lin Y, Zahoor H, Shuai Y, Butterfield LH, Ringquist S, Gogas H, Sander C, Lee S, Agarwala SS, Kirwood JM. Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients. PLoS One 2015;10:e0132745. [PMID: 26192408 DOI: 10.1371/journal.pone.0132745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
83 van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, Ibrahim SM, Fero M, Dijkmans BA, Tak PP, Verweij CL. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007;66:1008-14. [PMID: 17223656 DOI: 10.1136/ard.2006.063412] [Cited by in Crossref: 208] [Cited by in F6Publishing: 180] [Article Influence: 14.9] [Reference Citation Analysis]
84 Slavuljica I, Krmpotić A, Jonjić S. Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. Front Immunol 2011;2:85. [PMID: 22566874 DOI: 10.3389/fimmu.2011.00085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
85 Jounai K, Ikado K, Sugimura T, Ano Y, Braun J, Fujiwara D. Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells. PLoS One. 2012;7:e32588. [PMID: 22505996 DOI: 10.1371/journal.pone.0032588] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
86 Sabir N, Hussain T, Shah SZA, Zhao D, Zhou X. IFN-β: A Contentious Player in Host-Pathogen Interaction in Tuberculosis. Int J Mol Sci 2017;18:E2725. [PMID: 29258190 DOI: 10.3390/ijms18122725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
87 Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol 2009;66:483-9. [PMID: 19364933 DOI: 10.1001/archneurol.2009.50] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 10.3] [Reference Citation Analysis]
88 Barber SA, Herbst DS, Bullock BT, Gama L, Clements JE. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol 2004;10 Suppl 1:15-20. [PMID: 14982734 DOI: 10.1080/753312747] [Cited by in Crossref: 36] [Cited by in F6Publishing: 47] [Article Influence: 2.1] [Reference Citation Analysis]
89 Hastings AK, Erickson JJ, Schuster JE, Boyd KL, Tollefson SJ, Johnson M, Gilchuk P, Joyce S, Williams JV. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication. J Virol 2015;89:4405-20. [PMID: 25653440 DOI: 10.1128/JVI.03275-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
90 Agrawal A, Sridharan A, Prakash S, Agrawal H. Dendritic cells and aging: consequences for autoimmunity. Expert Rev Clin Immunol. 2012;8:73-80. [PMID: 22149342 DOI: 10.1586/eci.11.77] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
91 Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Brière F, Trinchieri G, Biron CA. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 2002;195:517-28. [PMID: 11854364 DOI: 10.1084/jem.20011672] [Cited by in Crossref: 355] [Cited by in F6Publishing: 337] [Article Influence: 18.7] [Reference Citation Analysis]
92 Swiecki M, McCartney SA, Wang Y, Colonna M. TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. J Leukoc Biol 2011;90:691-701. [PMID: 21844166 DOI: 10.1189/jlb.0311166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
93 Fitzgerald KA. The interferon inducible gene: Viperin. J Interferon Cytokine Res. 2011;31:131-135. [PMID: 21142818 DOI: 10.1089/jir.2010.0127] [Cited by in Crossref: 118] [Cited by in F6Publishing: 108] [Article Influence: 10.7] [Reference Citation Analysis]
94 Yoon CH, Lee ES, Lim DS, Bae YS. PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc Natl Acad Sci U S A 2009;106:7852-7. [PMID: 19416861 DOI: 10.1073/pnas.0812148106] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 6.6] [Reference Citation Analysis]
95 Quadt-Akabayov SR, Chill JH, Levy R, Kessler N, Anglister J. Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex. Protein Sci 2006;15:2656-68. [PMID: 17001036 DOI: 10.1110/ps.062283006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
96 Abel K, Alegria-Hartman MJ, Rothaeusler K, Marthas M, Miller CJ. The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J Virol 2002;76:8433-45. [PMID: 12134046 DOI: 10.1128/jvi.76.16.8433-8445.2002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
97 Qin L, Greenland JR, Moriya C, Cayabyab MJ, Letvin NL. Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo. J Virol 2007;81:10606-13. [PMID: 17652387 DOI: 10.1128/JVI.01000-07] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
98 Srivastava S, Koch LK, Campbell DJ. IFNαR signaling in effector but not regulatory T cells is required for immune dysregulation during type I IFN-dependent inflammatory disease. J Immunol 2014;193:2733-42. [PMID: 25092894 DOI: 10.4049/jimmunol.1401039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
99 Tähtinen S, Kaikkonen S, Merisalo-Soikkeli M, Grönberg-Vähä-Koskela S, Kanerva A, Parviainen S, Vähä-Koskela M, Hemminki A. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors. PLoS One 2015;10:e0131242. [PMID: 26107883 DOI: 10.1371/journal.pone.0131242] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
100 Malmgaard L, Salazar-Mather TP, Lewis CA, Biron CA. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J Virol. 2002;76:4520-4525. [PMID: 11932417 DOI: 10.1128/JVI.76.9.4520-4525.2002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
101 Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, van Riel D, de Jong T, Itamura S, Chan KH, Tashiro M, Osterhaus AD. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med. 2004;10:290-293. [PMID: 14981511 DOI: 10.1038/nm1001] [Cited by in Crossref: 285] [Cited by in F6Publishing: 251] [Article Influence: 16.8] [Reference Citation Analysis]
102 Hou W, So EY, Kim BS. Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog 2007;3:e124. [PMID: 17722981 DOI: 10.1371/journal.ppat.0030124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
103 Hall JC, Rosen A. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol. 2010;6:40-49. [PMID: 20046205 DOI: 10.1038/nrrheum.2009.237] [Cited by in Crossref: 161] [Cited by in F6Publishing: 142] [Article Influence: 14.6] [Reference Citation Analysis]
104 Lin CJ, Lin HJ, Chen TH, Hsu YA, Liu CS, Hwang GY, Wan L. Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression. PLoS One 2015;10:e0117602. [PMID: 25658356 DOI: 10.1371/journal.pone.0117602] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
105 Ashkar AA, Mossman KL, Coombes BK, Gyles CL, Mackenzie R. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog 2008;4:e1000233. [PMID: 19057665 DOI: 10.1371/journal.ppat.1000233] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 6.1] [Reference Citation Analysis]
106 van Campenhout MJH, van Bömmel F, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Berg T, Hansen BE, Janssen HLA. Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis B. J Viral Hepat 2020;27:610-9. [PMID: 32052503 DOI: 10.1111/jvh.13272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
107 Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 2004;101:15416-21. [PMID: 15492225 DOI: 10.1073/pnas.0406933101] [Cited by in Crossref: 366] [Cited by in F6Publishing: 345] [Article Influence: 21.5] [Reference Citation Analysis]
108 Yao Y, Higgs BW, Richman L, White B, Jallal B. Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus. Arthritis Res Ther 2010;12 Suppl 1:S6. [PMID: 20392292 DOI: 10.1186/ar2887] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
109 Park HJ, Stokes JA, Corr M, Yaksh TL. Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 2014;73:25-34. [PMID: 24162377 DOI: 10.1007/s00280-013-2304-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
110 Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 2012;13:954-62. [PMID: 22922364 DOI: 10.1038/ni.2397] [Cited by in Crossref: 287] [Cited by in F6Publishing: 267] [Article Influence: 31.9] [Reference Citation Analysis]
111 Schettini J, Mukherjee P. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin Dev Immunol 2008;2008:106321. [PMID: 19190769 DOI: 10.1155/2008/106321] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
112 Salazar-Mather TP, Lewis CA, Biron CA. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 2002;110:321-30. [PMID: 12163451 DOI: 10.1172/JCI15376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 54] [Article Influence: 0.2] [Reference Citation Analysis]
113 Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, Theofilopoulos AN. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003;197:777-88. [PMID: 12642605 DOI: 10.1084/jem.20021996] [Cited by in Crossref: 401] [Cited by in F6Publishing: 376] [Article Influence: 22.3] [Reference Citation Analysis]
114 Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 2007;3:e123. [PMID: 17722980 DOI: 10.1371/journal.ppat.0030123] [Cited by in Crossref: 124] [Cited by in F6Publishing: 117] [Article Influence: 8.9] [Reference Citation Analysis]
115 Kiladjian JJ, Giraudier S, Cassinat B. Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone. Leukemia. 2016;30:776-781. [PMID: 26601783 DOI: 10.1038/leu.2015.326] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
116 García-Sastre A. Antiviral response in pandemic influenza viruses. Emerg Infect Dis 2006;12:44-7. [PMID: 16494716 DOI: 10.3201/eid1201.051186] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
117 Tomer S, Chawla YK, Duseja A, Arora SK. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection. World J Gastroenterol 2016;22:5173-82. [PMID: 27298560 DOI: 10.3748/wjg.v22.i22.5173] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
118 Stavrou S, Feng Z, Lemon SM, Roos RP. Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway. J Virol 2010;84:9181-9. [PMID: 20610716 DOI: 10.1128/JVI.00603-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
119 Benlahrech A, Donaghy H, Rozis G, Goodier M, Klavinskis L, Gotch F, Patterson S. Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways. Sensors (Basel) 2009;9:386-403. [PMID: 22389607 DOI: 10.3390/s90100386] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
120 Nicholas C, Lesinski GB. Immunomodulatory cytokines as therapeutic agents for melanoma. Immunotherapy 2011;3:673-90. [PMID: 21554095 DOI: 10.2217/imt.11.45] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
121 Mahieu T, Libert C. Should we inhibit type I interferons in sepsis? Infect Immun 2007;75:22-9. [PMID: 17000722 DOI: 10.1128/IAI.00829-06] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
122 Müller-Quernheim UC, Potthast L, Müller-Quernheim J, Zissel G. Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro. J Interferon Cytokine Res 2012;32:169-77. [PMID: 22280057 DOI: 10.1089/jir.2011.0020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
123 Hagiwara S, Kudo M, Nakatani T, Sakaguchi Y, Nagashima M, Fukuta N, Kimura M, Hayakawa S, Munakata H. Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. Br J Cancer 2007;97:1532-7. [PMID: 17971768 DOI: 10.1038/sj.bjc.6604058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
124 Pontiroli F, Dussurget O, Zanoni I, Urbano M, Beretta O, Granucci F, Ricciardi-Castagnoli P, Cossart P, Foti M. The timing of IFNβ production affects early innate responses to Listeria monocytogenes and determines the overall outcome of lethal infection. PLoS One 2012;7:e43455. [PMID: 22912878 DOI: 10.1371/journal.pone.0043455] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
125 Malakhova OA, Kim KI, Luo JK, Zou W, Kumar KG, Fuchs SY, Shuai K, Zhang DE. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 2006;25:2358-2367. [PMID: 16710296 DOI: 10.1038/sj.emboj.7601149] [Cited by in Crossref: 277] [Cited by in F6Publishing: 253] [Article Influence: 18.5] [Reference Citation Analysis]
126 Al-Khatib K, Williams BR, Silverman RH, Halford W, Carr DJ. Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. J Immunol 2004;172:5638-47. [PMID: 15100308 DOI: 10.4049/jimmunol.172.9.5638] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
127 Olofsson P, Nerstedt A, Hultqvist M, Nilsson EC, Andersson S, Bergelin A, Holmdahl R. Arthritis suppression by NADPH activation operates through an interferon-beta pathway. BMC Biol 2007;5:19. [PMID: 17490473 DOI: 10.1186/1741-7007-5-19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
128 Yang R, Murillo FM, Cui H, Blosser R, Uematsu S, Takeda K, Akira S, Viscidi RP, Roden RB. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J Virol 2004;78:11152-60. [PMID: 15452235 DOI: 10.1128/JVI.78.20.11152-11160.2004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
129 Papasavvas E, Azzoni L, Kossenkov AV, Dawany N, Morales KH, Fair M, Ross BN, Lynn K, Mackiewicz A, Mounzer K, Tebas P, Jacobson JM, Kostman JR, Showe L, Montaner LJ. NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects. J Immunol 2019;203:705-17. [PMID: 31253727 DOI: 10.4049/jimmunol.1801511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
130 Kalliolias GD, Ivashkiv LB. Overview of the biology of type I interferons. Arthritis Res Ther 2010;12 Suppl 1:S1. [PMID: 20392288 DOI: 10.1186/ar2881] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
131 Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, Hu Y, Becknell B, Abood G, Chaudhury AR, Magro C, Durbin J, Carson WE. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest. 2003;112:170-180. [PMID: 12865406 DOI: 10.1172/jci16603] [Cited by in Crossref: 76] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
132 Bird MD, Chu CF, Johnson AJ, Milligan GN. Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon. J Virol 2007;81:423-6. [PMID: 17065206 DOI: 10.1128/JVI.01455-06] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
133 Lau JF, Nusinzon I, Burakov D, Freedman LP, Horvath CM. Role of metazoan mediator proteins in interferon-responsive transcription. Mol Cell Biol 2003;23:620-8. [PMID: 12509459 DOI: 10.1128/MCB.23.2.620-628.2003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
134 Culley FJ. Natural killer cells in infection and inflammation of the lung. Immunology 2009;128:151-63. [PMID: 19740372 DOI: 10.1111/j.1365-2567.2009.03167.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 143] [Article Influence: 12.5] [Reference Citation Analysis]
135 Kim TK, Bheda-Malge A, Lin Y, Sreekrishna K, Adams R, Robinson MK, Bascom CC, Tiesman JP, Isfort RJ, Gelinas R. A systems approach to understanding human rhinovirus and influenza virus infection. Virology 2015;486:146-57. [PMID: 26437235 DOI: 10.1016/j.virol.2015.08.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
136 Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, Miller CJ. Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol 2008;37:26-30. [PMID: 18199069 DOI: 10.1111/j.1600-0684.2007.00221.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
137 Malakhova OA, Zhang DE. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 2008;283:8783-7. [PMID: 18287095 DOI: 10.1074/jbc.C800030200] [Cited by in Crossref: 129] [Cited by in F6Publishing: 98] [Article Influence: 9.9] [Reference Citation Analysis]
138 Larocque L, Bliu A, Xu R, Diress A, Wang J, Lin R, He R, Girard M, Li X. Bioactivity determination of native and variant forms of therapeutic interferons. J Biomed Biotechnol 2011;2011:174615. [PMID: 21403871 DOI: 10.1155/2011/174615] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
139 Srivatsan S, Swiecki M, Otero K, Cella M, Shaw AS. CD2-associated protein regulates plasmacytoid dendritic cell migration, but is dispensable for their development and cytokine production. J Immunol 2013;191:5933-40. [PMID: 24218450 DOI: 10.4049/jimmunol.1300454] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
140 Liu L, Fan W, Zhang H, Zhang S, Cui L, Wang M, Bai X, Yang W, Sun L, Yang L, Liu W, Li J. Interferon as a Mucosal Adjuvant for an Influenza Vaccine in Pigs. Virol Sin 2019;34:324-33. [PMID: 30989429 DOI: 10.1007/s12250-019-00102-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
141 Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol. 2006;80:4501-4509. [PMID: 16611910 DOI: 10.1128/jvi.80.9.4501-4509.2006] [Cited by in Crossref: 424] [Cited by in F6Publishing: 248] [Article Influence: 28.3] [Reference Citation Analysis]
142 Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 2012;8:e1002712. [PMID: 22615570 DOI: 10.1371/journal.ppat.1002712] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 12.9] [Reference Citation Analysis]
143 Asselin-Paturel C, Brizard G, Chemin K, Boonstra A, O'Garra A, Vicari A, Trinchieri G. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005;201:1157-67. [PMID: 15795237 DOI: 10.1084/jem.20041930] [Cited by in Crossref: 235] [Cited by in F6Publishing: 229] [Article Influence: 14.7] [Reference Citation Analysis]
144 Vollstedt S, Arnold S, Schwerdel C, Franchini M, Alber G, Di Santo JP, Ackermann M, Suter M. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 2004;78:3846-50. [PMID: 15047800 DOI: 10.1128/jvi.78.8.3846-3850.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
145 Heinrich MJ, Purcell CA, Pruijssers AJ, Zhao Y, Spurlock CF 3rd, Sriram S, Ogden KM, Dermody TS, Scholz MB, Crooke PS 3rd, Karijolich J, Aune TM. Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis. J Autoimmun 2019;100:40-51. [PMID: 30826177 DOI: 10.1016/j.jaut.2019.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
146 Hastings AK, Amato KR, Wen SC, Peterson LS, Williams JV. Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation. Virology 2016;494:248-56. [PMID: 27131212 DOI: 10.1016/j.virol.2016.04.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
147 Olson JK. Effect of the innate immune response on development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirol 2014;20:427-36. [PMID: 24981833 DOI: 10.1007/s13365-014-0262-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
148 Gil MP, Ploquin MJ, Watford WT, Lee SH, Kim K, Wang X, Kanno Y, O'Shea JJ, Biron CA. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 2012;120:3718-28. [PMID: 22968462 DOI: 10.1182/blood-2012-05-428672] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
149 Baum A, García-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids. 2010;38:1283-1299. [PMID: 19882216 DOI: 10.1007/s00726-009-0374-0] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 7.4] [Reference Citation Analysis]
150 Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, Schmidt RE, Levine B, Virgin HW 4th. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 2005;79:13974-83. [PMID: 16254333 DOI: 10.1128/JVI.79.22.13974-13983.2005] [Cited by in Crossref: 196] [Cited by in F6Publishing: 130] [Article Influence: 13.1] [Reference Citation Analysis]
151 Kolodziej H. Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs® 7630) in the Context of Health Promotion. Pharmaceuticals (Basel) 2011;4:1295-314. [PMID: 27721327 DOI: 10.3390/ph4101295] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
152 Nusinzon I, Horvath CM. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci U S A 2003;100:14742-7. [PMID: 14645718 DOI: 10.1073/pnas.2433987100] [Cited by in Crossref: 197] [Cited by in F6Publishing: 195] [Article Influence: 10.9] [Reference Citation Analysis]
153 Carr DJ, Noisakran S. The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon. J Virol 2002;76:9398-406. [PMID: 12186922 DOI: 10.1128/jvi.76.18.9398-9406.2002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
154 Majoros A, Platanitis E, Kernbauer-Hölzl E, Rosebrock F, Müller M, Decker T. Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses. Front Immunol 2017;8:29. [PMID: 28184222 DOI: 10.3389/fimmu.2017.00029] [Cited by in Crossref: 133] [Cited by in F6Publishing: 114] [Article Influence: 33.3] [Reference Citation Analysis]
155 Puttur F, Arnold-Schrauf C, Lahl K, Solmaz G, Lindenberg M, Mayer CT, Gohmert M, Swallow M, van Helt C, Schmitt H, Nitschke L, Lambrecht BN, Lang R, Messerle M, Sparwasser T. Absence of Siglec-H in MCMV infection elevates interferon alpha production but does not enhance viral clearance. PLoS Pathog 2013;9:e1003648. [PMID: 24086137 DOI: 10.1371/journal.ppat.1003648] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
156 Honda K, Mizutani T, Taniguchi T. Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc Natl Acad Sci U S A 2004;101:2416-21. [PMID: 14983024 DOI: 10.1073/pnas.0307336101] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
157 Barton ES, Lutzke ML, Rochford R, Virgin HW 4th. Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol 2005;79:14149-60. [PMID: 16254350 DOI: 10.1128/JVI.79.22.14149-14160.2005] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
158 Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, Jewell NA, Hammond S, Flano E, Durbin RK, García-Sastre A, Durbin JE. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol 2006;80:1130-9. [PMID: 16414990 DOI: 10.1128/JVI.80.3.1130-1139.2006] [Cited by in Crossref: 89] [Cited by in F6Publishing: 66] [Article Influence: 5.9] [Reference Citation Analysis]
159 Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, Akira S, Guiney DG. Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun. 2007;75:2408-2414. [PMID: 17353291 DOI: 10.1128/iai.01794-06] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
160 Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT Jr, Kottilil S, Lifson JD, Metcalf JA, Lempicki RA, Connors M. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol 2008;82:3997-4006. [PMID: 18256146 DOI: 10.1128/JVI.01545-07] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
161 Liu CC, Gao YJ, Luo H, Berta T, Xu ZZ, Ji RR, Tan PH. Interferon alpha inhibits spinal cord synaptic and nociceptive transmission via neuronal-glial interactions. Sci Rep 2016;6:34356. [PMID: 27670299 DOI: 10.1038/srep34356] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
162 Yim HY, Yang Y, Lim JS, Lee MS, Zhang DE, Kim KI. The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-α/β-mediated apoptosis in Ubp43-deficient hematopoietic cells. Biochem Biophys Res Commun 2012;423:436-40. [PMID: 22683641 DOI: 10.1016/j.bbrc.2012.05.154] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
163 Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P, Ryan MD, Wileman T. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol 2005;79:4382-95. [PMID: 15767438 DOI: 10.1128/JVI.79.7.4382-4395.2005] [Cited by in Crossref: 101] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
164 Van de Walle GR, Jarosinski KW, Osterrieder N. Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection. J Virol 2008;82:6090-7. [PMID: 18385255 DOI: 10.1128/JVI.00098-08] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
165 Li HS, Gelbard A, Martinez GJ, Esashi E, Zhang H, Nguyen-Jackson H, Liu YJ, Overwijk WW, Watowich SS. Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood 2011;118:3879-89. [PMID: 21828128 DOI: 10.1182/blood-2011-04-349761] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
166 Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfinbarger JB, Bloom ME. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 2005;79:12828-39. [PMID: 16188985 DOI: 10.1128/JVI.79.20.12828-12839.2005] [Cited by in Crossref: 227] [Cited by in F6Publishing: 134] [Article Influence: 14.2] [Reference Citation Analysis]
167 Meier WA, Husmann RJ, Schnitzlein WM, Osorio FA, Lunney JK, Zuckermann FA. Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2004;102:299-314. [PMID: 15507313 DOI: 10.1016/j.vetimm.2004.09.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
168 Conrady CD, Drevets DA, Carr DJ. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 2010;220:1-9. [PMID: 19819030 DOI: 10.1016/j.jneuroim.2009.09.013] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 7.8] [Reference Citation Analysis]
169 Sridharan A, Esposo M, Kaushal K, Tay J, Osann K, Agrawal S, Gupta S, Agrawal A. Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age (Dordr) 2011;33:363-76. [PMID: 20953722 DOI: 10.1007/s11357-010-9191-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
170 Pulverer JE, Rand U, Lienenklaus S, Kugel D, Zietara N, Kochs G, Naumann R, Weiss S, Staeheli P, Hauser H, Köster M. Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 2010;84:8626-38. [PMID: 20573823 DOI: 10.1128/JVI.00303-10] [Cited by in Crossref: 82] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
171 Di Scala M, Gil-Fariña I, Vanrell L, Sánchez-Bayona R, Alignani D, Olagüe C, Vales A, Berraondo P, Prieto J, González-Aseguinolaza G. Chronic exposure to IFNα drives medullar lymphopoiesis towards T-cell differentiation in mice. Haematologica 2015;100:1014-22. [PMID: 25715405 DOI: 10.3324/haematol.2014.115410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
172 Jones HM, Chan PL, van der Graaf PH, Webster R. Use of modelling and simulation techniques to support decision making on the progression of PF-04878691, a TLR7 agonist being developed for hepatitis C. Br J Clin Pharmacol 2012;73:77-92. [PMID: 21689140 DOI: 10.1111/j.1365-2125.2011.04047.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
173 Kim CS, Kim JY, Kim HJ. The effects of a single bout pilates exercise on mRNA expression of bone metabolic cytokines in osteopenia women. J Exerc Nutrition Biochem 2014;18:69-78. [PMID: 25566441 DOI: 10.5717/jenb.2014.18.1.69] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
174 Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 2008;226:41-56. [PMID: 19161415 DOI: 10.1111/j.1600-065X.2008.00707.x] [Cited by in Crossref: 183] [Cited by in F6Publishing: 102] [Article Influence: 15.3] [Reference Citation Analysis]
175 Sie C, Korn T. Dendritic cells in central nervous system autoimmunity. Semin Immunopathol 2017;39:99-111. [PMID: 27888330 DOI: 10.1007/s00281-016-0608-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
176 Wickstrum JR, Hong KJ, Bokhari S, Reed N, McWilliams N, Horvat RT, Parmely MJ. Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis. Infect Immun 2007;75:1335-42. [PMID: 17178781 DOI: 10.1128/IAI.01203-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
177 Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvänen AC, Rönnblom L, Behrens TW, Graham RR, Vyse TJ. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 2011;7:e1002341. [PMID: 22046141 DOI: 10.1371/journal.pgen.1002341] [Cited by in Crossref: 191] [Cited by in F6Publishing: 180] [Article Influence: 19.1] [Reference Citation Analysis]
178 Jeon YJ, Yoo HM, Chung CH. ISG15 and immune diseases. Biochim Biophys Acta. 2010;1802:485-496. [PMID: 20153823 DOI: 10.1016/j.bbadis.2010.02.006] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 9.6] [Reference Citation Analysis]
179 Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F, Wang G. The Mechanism behind Influenza Virus Cytokine Storm. Viruses 2021;13:1362. [PMID: 34372568 DOI: 10.3390/v13071362] [Reference Citation Analysis]
180 Goodman AG, Zeng H, Proll SC, Peng X, Cillóniz C, Carter VS, Korth MJ, Tumpey TM, Katze MG. The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling. J Virol 2010;84:2027-37. [PMID: 19939913 DOI: 10.1128/JVI.01595-09] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
181 McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat Rev Immunol 2015;15:87-103. [PMID: 25614319 DOI: 10.1038/nri3787] [Cited by in Crossref: 914] [Cited by in F6Publishing: 817] [Article Influence: 152.3] [Reference Citation Analysis]
182 von Glehn F, Santos LM, Balashov KE. Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis. Immunotherapy. 2012;4:1053-1061. [PMID: 23148757 DOI: 10.2217/imt.12.117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
183 Miller LC, Lager KM, Kehrli ME Jr. Role of Toll-like receptors in activation of porcine alveolar macrophages by porcine reproductive and respiratory syndrome virus. Clin Vaccine Immunol 2009;16:360-5. [PMID: 19144789 DOI: 10.1128/CVI.00269-08] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
184 Watowich SS, Liu YJ. Mechanisms regulating dendritic cell specification and development. Immunol Rev 2010;238:76-92. [PMID: 20969586 DOI: 10.1111/j.1600-065X.2010.00949.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
185 Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med 2016;213:225-33. [PMID: 26755706 DOI: 10.1084/jem.20150712] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 19.8] [Reference Citation Analysis]
186 Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002;195:F9-14. [PMID: 11828015 DOI: 10.1084/jem.20012040] [Cited by in Crossref: 203] [Cited by in F6Publishing: 173] [Article Influence: 10.7] [Reference Citation Analysis]
187 Loving CL, Osorio FA, Murtaugh MP, Zuckermann FA. Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus. Vet Immunol Immunopathol 2015;167:1-14. [PMID: 26209116 DOI: 10.1016/j.vetimm.2015.07.003] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 17.3] [Reference Citation Analysis]
188 Tan XM, Tang Y, Yang YF, Song HM, Zhang YZ. Gene cloning, sequencing, expression and biological activity of giant panda (Ailuropoda melanoleuca) interferon-alpha. Mol Immunol 2007;44:3061-9. [PMID: 17346794 DOI: 10.1016/j.molimm.2006.12.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]